ArticleDrug and alcohol review2025
Recreational nitrous oxide use in France in 2022: Results from a nationwide representative sample of adults.
Article in Drug and alcohol review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recreational nitrous oxide use in France in 2022: Results from a nationwide representative sample of adults.Drug and alcohol review · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionThe increasing heavy and sustained use of nitrous oxide (N
methodsBetween 2 March and 9 July 2022, we conducted a nationwide survey of a random sample of adults in France to estimate the prevalence of N
resultsOf the study's 3229 participants, we estimated that 75.2% (95% confidence interval [CI] 73.2-77.2) of the French adult population had heard of N DISCUSSION AND
conclusionsWe estimated that in 2022 three-quarters of adults in France were aware of recreational N
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.